HALOZYME THERAPEUTICS INC shareholders Q2 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 369 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Arbor Investment Advisors, LLC 17,950$647,4570.11%
CAMPBELL NEWMAN ASSET MANAGEMENT INC 34,656$1,250,0420.11%
Alliance Wealth Advisors, LLC /UT 7,808$281,6350.10%
ExodusPoint Capital Management, LP 339,963$12,2620.10%
SEGALL BRYANT & HAMILL, LLC 263,088$9,489,5850.10%
CIM INVESTMENT MANAGEMENT INC 7,991$288,2350.10%
PROFUND ADVISORS LLC 50,221$1,811,4710.10%
Trexquant Investment LP 101,405$3,657,6780.10%
Candriam S.C.A. 362,143$13,062,4980.09%
GLOBEFLEX CAPITAL L P 22,980$828,8890.09%
CONGRESS ASSET MANAGEMENT CO /MA 289,104$10,427,9810.09%
State of Wyoming 8,112$292,6000.08%
Headlands Technologies LLC 7,121$256,8540.08%
Edgestream Partners, L.P. 23,806$858,6820.08%
CORNERCAP INVESTMENT COUNSEL INC 12,204$440,1980.08%
GLENMEDE TRUST CO NA 346,456$13,187,1580.08%
Ifrah Financial Services, Inc. 6,497$234,3440.07%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 170,198$6,139,0420.07%
DUALITY ADVISERS, LP 15,384$554,9010.07%
FULLER & THALER ASSET MANAGEMENT, INC. 338,002$12,191,7220.07%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.